Labyrinth Devices

Labyrinth Devices is a biotechnology company specializing in high-throughput, label-free microfluidic technologies for the isolation and characterization of rare cells from blood samples. Spun out from the University of Michigan, the company's core technology, the Labyrinth chip, utilizes hydrodynamic forces in a spiral microchannel to separate cells based on size without the need for biomarkers. This approach allows for the recovery of viable circulating tumor cells (CTCs), clusters, and immune cells like neutrophils for downstream analysis in oncology and infectious disease research. The platform is designed to provide a more comprehensive "liquid biopsy" by capturing heterogeneous cell populations that traditional antibody-based methods might miss. By enabling the study of live, intact cells, Labyrinth Devices supports advancements in personalized medicine and biomarker discovery.